Trial Profile
A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jan 2010
Price :
$35
*
At a glance
- Drugs BMS 641988 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacokinetics
- 21 Jul 2009 Actual patient number (54) added as reported by ClinicalTrials.gov.
- 21 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Mar 2009 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.